Exploring Genetic Markers in Susceptibility of Lupus Nephritis through MCP-1 and MIF Polymorphisms

Document Type : Original Article

Authors

1 Department of Zoology, Faculty of Science, Tanta University, Tanta 31527, Egypt.

2 Zoology Department, Faculty of science Tanta University, 31527, El-Gharbia, Egypt.

3 Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Abstract

Background: Lupus nephritis (LN) has not been fully elucidated genetically. Some distinct genetic factors have been demonstrated to be associated with LN development. The contributions of monocyte chemoattractant protein-1 (MCP-1) -2518A/G and macrophage migration inhibitory factor (MIF) -173 G/C single nucleotide polymorphisms (SNPs) to LN development have not been elucidated. This study aimed to evaluate the potential role of MCP-1 -2518A/G and MIF -173 G/C SNPs in LN prediction. Methods: There were 52 participants (26 LN patients and 26 healthy controls). MCP-1 -2518A/G and MIF -173 G/C SNPs were analyzed by PCR. Results: There was no significant difference (P=0.93) in the distribution of wild (AA) and mutant (AG/GG) genotypes of -2518 MCP-1 A/G between control (50% vs. 50%) and LN (46% vs. 54%) groups. Despite that, -173 MIF mutant (GC/CC) genotypes were higher in LN patients (69%) compared to controls (35%) with the predominance of heterozygous (GC) genotype. Carriers of MIF-173*C allele were more common (P=0.011) in LN patients (42%) than controls (19%) and had an increased systemic-onset risk (OR 3.0; P=0.0124; 95% CI 1.24–7.44). The best inheritance model is the log-additive model, which yielded the strongest association with the smallest AIC and the minimum BIC (P=0.009, AIC=69.3, BIC=73.2). Conclusion: The present findings provide new evidence that -173 MIF G/C gene polymorphism can play an important role in the development of LN among Egyptians with systemic lupus erythematosus.

Keywords

Main Subjects



Articles in Press, Accepted Manuscript
Available Online from 18 February 2025
  • Receive Date: 14 January 2025
  • Revise Date: 16 February 2025
  • Accept Date: 18 February 2025